Colonic adenocarcinomas rapidly induced by the combined treatment with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and dextran sodium sulfate in male ICR mice possess beta-catenin gene mutations and increases immunoreactivity for beta-catenin, cyclooxygenase-2 and inducible nitric oxide synthase

Heterocyclic amines are known to be important environmental carcinogens in several organs including the colon. The aim of this study was to induce colonic epithelial malignancies within a short-term period and analyze the expression of cycooxygenase (COX)-2, inducible nitric oxide synthase (iNOS) and beta-catenin, and mutations of beta-catenin gene in induced tumors. Male Crj: CD-1 mice were given a single i.g. administration (200 mg/kg body wt) of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) or 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) followed by 2% dextran sodium sulfate (DSS) in the drinking water for a week. The expression of beta-catenin, COX-2 and iNOS was immunohistochemically assessed in colonic epithelial lesions and the beta-catenin gene mutations in colonic adenocarcinomas induced were analyzed by the single strand conformation polymorphism method, restriction enzyme fragment length polymorphism and direct sequencing. At week 16, a high incidence of colonic neoplasms with dysplastic lesions developed in mice that received PhIP and DSS, but only a few developed in those given MeIQx and DSS. Immunohistochemically, the adenocarcinomas induced were all positive for three proteins. All seven adenocarcinomas induced by PhIP and DSS have mutations. The findings suggest that DSS exerts powerful tumor-promoting effects on PhIP-initiated colon carcinogenesis in mice and this mouse model is useful for investigating environment-related colon carcinogenesis within a short-term period.

[1]  Takuji Tanaka,et al.  Sequential observations on the occurrence of preneoplastic and neoplastic lesions in mouse colon treated with azoxymethane and dextran sodium sulfate , 2004, Cancer science.

[2]  Takuji Tanaka,et al.  A novel inflammation‐related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate , 2003, Cancer science.

[3]  M. Yasutomi,et al.  Changes in Colorectal Cancer During a 20-Year Period: An Extended Report From the Multi-Institutional Registry of Large Bowel Cancer, Japan , 2003, Diseases of the colon and rectum.

[4]  T. Sugimura,et al.  Characterization of dysplastic aberrant crypt foci in the rat colon induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. , 2003, The American journal of pathology.

[5]  C. Szabó,et al.  Part II: Beneficial Effects of the Peroxynitrite Decomposition Catalyst FP15 in Murine Models of Arthritis and Colitis , 2002, Molecular medicine.

[6]  J. Weisburger,et al.  Comments on the history and importance of aromatic and heterocyclic amines in public health. , 2002, Mutation research.

[7]  T. Sugimura,et al.  A rat colon cancer model induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, PhIP. , 2002, Mutation research.

[8]  J. Liao,et al.  Inhibition of chronic ulcerative colitis-associated colorectal adenocarcinoma development in a murine model by N-acetylcysteine. , 2002, Carcinogenesis.

[9]  T. Sugimura,et al.  Induction of Intestinal Tumors and Lymphomas in C57BL/6N Mice by a Food‐borne Carcinogen, 2‐Amino‐l‐methyl‐6‐phenylimidazo[4,5‐b]pyridine , 2002, Japanese journal of cancer research : Gann.

[10]  A. Benner,et al.  Predominant mutation of codon 41 of the beta-catenin proto-oncogene in rat colon tumors induced by 1,2-dimethylhydrazine using a complete carcinogenic protocol. , 2001, Carcinogenesis.

[11]  A. Nishikawa,et al.  Essential similarities between spontaneous and MeIQx-promoted aberrant crypt foci in the F344 rat colon. , 2001, Cancer letters.

[12]  P K Lala,et al.  Role of nitric oxide in carcinogenesis and tumour progression. , 2001, The Lancet. Oncology.

[13]  H. Toyoshima,et al.  [Epidemiology and primary prevention of colorectal cancer]. , 2001, Gan to kagaku ryoho. Cancer & chemotherapy.

[14]  W. Franklin,et al.  Expression of beta-catenin and full-length APC protein in normal and neoplastic colonic tissues. , 2000, Carcinogenesis.

[15]  M. Inoue,et al.  More Frequent β‐Catenin Gene Mutations in Adenomas than in Aberrant Crypt Foci or Adenocarcinomas in the Large Intestines of 2‐Amino‐1‐methyl‐6‐phenylimidazo[4,5‐b]pyridine (PhIP)‐treated Rats , 2000, Japanese journal of cancer research : Gann.

[16]  T. Sugimura,et al.  Altered expression of beta-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis. , 2000, Carcinogenesis.

[17]  T. Sugimura,et al.  Food Borne Carcinogens: Heterocyclic Amines , 2000 .

[18]  A. Murakami,et al.  Prevention of colonic aberrant crypt foci by dietary feeding of garcinol in male F344 rats. , 2000, Carcinogenesis.

[19]  T. Sugimura,et al.  Frequent mutations of the beta-catenin gene in mouse colon tumors induced by azoxymethane. , 2000, Carcinogenesis.

[20]  T. Sugimura,et al.  Nutrition and dietary carcinogens. , 2000, Carcinogenesis.

[21]  M. Nagao,et al.  A new approach to risk estimation of food-borne carcinogens--heterocyclic amines--based on molecular information. , 1999, Mutation research.

[22]  T. Sugimura,et al.  Difference in Target Organs in Carcinogenesis with a Heterocyclic Amine, 2‐Amino‐3,4‐dimethylimidazo[4,5‐f]quinoline, in Different Strains of Mice , 1999, Japanese journal of cancer research : Gann.

[23]  T. Sugimura,et al.  Genetic analysis of the susceptibility in rats to aberrant crypt foci formation by 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine, PhIP. , 1999, Cancer letters.

[24]  Frank McCormick,et al.  β-Catenin regulates expression of cyclin D1 in colon carcinoma cells , 1999, Nature.

[25]  D. Winterstein,et al.  Differential expression of prostaglandin endoperoxide H synthase-2 and formation of activated beta-catenin-LEF-1 transcription complex in mouse colonic epithelial cells contrasting in Apc. , 1999, Carcinogenesis.

[26]  K. Subbaramaiah,et al.  Transcriptional activation of cyclooxygenase-2 in Wnt-1-transformed mouse mammary epithelial cells. , 1999, Cancer research.

[27]  T. Sugimura,et al.  Frequent mutations of the rat β‐catenin gene in colon cancers induced by methylazoxymethanol acetate plus 1‐hydroxyanthraquinone , 1999, Molecular carcinogenesis.

[28]  A. Sparks,et al.  Identification of c-MYC as a target of the APC pathway. , 1998, Science.

[29]  Hideki Yamamoto,et al.  Axin, a Negative Regulator of the Wnt Signaling Pathway, Directly Interacts with Adenomatous Polyposis Coli and Regulates the Stabilization of β-Catenin* , 1998, The Journal of Biological Chemistry.

[30]  T. Sugimura,et al.  High frequency of beta-catenin (ctnnb1) mutations in the colon tumors induced by two heterocyclic amines in the F344 rat. , 1998, Cancer research.

[31]  Bert Vogelstein,et al.  Mutational Analysis of the APC/β-Catenin/Tcf Pathway in Colorectal Cancer , 1998 .

[32]  R. Sinha,et al.  Exposure assessment of heterocyclic amines (HCAs) in epidemiologic studies. , 1997, Mutation research.

[33]  T. Sugimura,et al.  Overview of carcinogenic heterocyclic amines. , 1997, Mutation research.

[34]  Hans Clevers,et al.  Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC , 1997, Science.

[35]  E. Kristiansen.  The role of aberrant crypt foci induced by the two heterocyclic amines 2-amino-3-methyl-imidazo[4,5-f]quinoline (IQ) and 2-amino-1-methyl-6-phenyl-imidazo[4,5-b]pyridine (PhIP) in the development of colon cancer in mice. , 1996, Cancer letters.

[36]  Raymond L. White,et al.  Self-Promotion? Intimate Connections Between APC and Prostaglandin H Synthase-2 , 1996, Cell.

[37]  R. Moon,et al.  Signal transduction through beta-catenin and specification of cell fate during embryogenesis. , 1996, Genes & development.

[38]  Masatoshi Watanabe,et al.  Efficient Method for Rapid Induction of Aberrant Crypt Foci in Rats with 2‐Amino‐1‐methyl‐6‐phenylimidazo[4,5‐b]pyridine , 1996, Japanese journal of cancer research : Gann.

[39]  H. Bartsch,et al.  Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. , 1994, Mutation research.

[40]  T. Sugimura,et al.  Exposure to heterocyclic amines. , 1993, Environmental health perspectives.

[41]  T. Sugimura,et al.  Adduct Formation at C‐8 of Guanine on in vitro Reaction f the Ultimate Form of 2‐Amino‐l‐methyl‐6‐phenylimidazo[4,5‐b]pyridine with 2′‐Deoxyguanosine and Its Phosphate Esters , 1992, Japanese journal of cancer research : Gann.

[42]  Bert Vogelstein,et al.  APC mutations occur early during colorectal tumorigenesis , 1992, Nature.

[43]  S Ichii,et al.  Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. , 1992, Human molecular genetics.

[44]  T. Sugimura,et al.  Food-derived mutagens and carcinogens. , 1992, Cancer research.

[45]  G. Steineck,et al.  Meat, cooking methods and colorectal cancer: A case‐referent study in Stockholm , 1991, International journal of cancer.

[46]  N Ito,et al.  A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). , 1991, Carcinogenesis.

[47]  R P Bird,et al.  Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. , 1987, Cancer letters.

[48]  J. Ward.  Morphogenesis of chemically induced neoplasms of the colon and small intestine in rats. , 1974, Laboratory investigation; a journal of technical methods and pathology.

[49]  T. Norat,et al.  Meat cooking and cancer risk. , 2002, IARC scientific publications.

[50]  T. Sugimura,et al.  Efficient induction of rat large intestinal tumors with a new spectrum of mutations by intermittent administration of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in combination with a high fat diet. , 2002, Carcinogenesis.

[51]  C. Rao,et al.  Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor. , 2002, Cancer research.

[52]  T. Sugimura,et al.  Beta-catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors. , 1998, Cancer research.

[53]  T. Sugimura,et al.  Induction of aberrant crypt foci in C57BL/6N mice by 2-amino-9H-pyrido[2,3-b]indole (A alphaC) and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx). , 1997, Cancer letters.